Pain and its treatments

European Neurology

Volumn 38, Issue 3, 1997, Pages 209-215

  Cesaro, Pierre ^a   Ollat, Hélène ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE   (France)

Author keywords

Analgesia; Nervous system; Nociception; Opioids; Pain; Pharmacology; Treatments

Indexed keywords

ENDORPHIN; NEUROPEPTIDE; OPIATE RECEPTOR; SUBSTANCE P;

ANALGESIA; ARTICLE; HUMAN; INSULA; NERVOUS SYSTEM; NOCICEPTION; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THALAMUS NUCLEUS; TISSUE INJURY;

ANALGESIA; ANALGESICS; ANTIDEPRESSIVE AGENTS; HUMANS; NERVOUS SYSTEM DISEASES; NOCICEPTORS; PAIN; RECEPTORS, NEUROKININ-1;

EID: 0030962810     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113375     Document Type: Article

References (36)

1. Merskcy H: The definition of pain, Eur J Psychiatry 1991;6:153-159.
2. Anand KJS, Craig KD: New perspectives on the definition of pain, Pain 1996;67:3-6
3. Besson JM, Chaouch A: Peripheral and spinal mechanisms of nociception, Physiol Rev 1987; 67:67-186.
4. Woolf CJ: Windup and central sensitization are not equivalent, Pain 1996;66:15-108.
5. Ren K: Primary afferents and inflammatory hyperexcitability, Pain 1996;67:1-2.
6. Traub RJ: The spinal contribution of SP to the generation and maintenance to the inflammatory hyperalgesia in the rat, Pain 1996:67:151 - 161.
7. Davar G, Shalish C, Blumenfeld A, Brcakefield X: Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type 11. Pain 1996;67:135-139.
8. Ollat H, Cesaro P: Pharmacology of neuropathic pain Clin Ncuropharmacol 1996:18: 391-404.
9. Bushnell MC, Duncan GH: Sensory and affective aspects of pain perception: Is medial thalamus restricted to emotional issues? Exp Brain Res 1989;78:415-418.
10. Craig AD, Bushnell MC, Zhang ET, Blomqvist A: A thalamic nucleus specific for pain and temperature sensation, Nature 1994:372:770- 773.
11. Hsieh J-C, Hannerz J, Ingvar M: Right lateral-ised central processing for pain of nitroglycerin-induced cluster headache, Pain 1996:67:59- 68.
12. Jadad AR, Carroll D, Moore RA, McQuay H: Developing a database of published reports of randomised clinical trials of analgesics, Pain 1996:66:239-246.
13. Moore RA, Me Quay H, Gavaghan G: Deriving dichotomous outcome measures from continuous data in randomised clinical trials of analgesics, Pain 1996:66:229-238.
14. Klaber Moffett JA, Richardson PH, Frost H, Osborn A: A placebo-controlled double blind trial to evaluate the effectiveness of pulsed short wave therapy for ostcoarthritic hip and knee pain, Pain 1996:66:121-128.
15. Stubhaug A, Grimstad J, Breivik H: Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopedic surgery: A randomised, double blind placebo and standard active drug comparison, Pain 1995:62:111-118.
16. Barholdy J, Sperling K, Ibsen M, Eliasen K, Mogcnsen T: Preoperativc infiltration of the surgical area enhances postoperative analgcsis of a combined low dose epidural bupivacainc and morphine regimen alter upper abdominal surgery, Acta Anesthcsiol Scand 1994:38:262-265.
17. Cherny NI, Thaler HT, Friedlander-KIar MS, Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies, Ncurologv 1994:44: 857-861.
18. Attal N, Kayser V, Guilbaud G: The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: A study in a rat model of peripheral mononcuropathy, Brain Res 1990.525:170-174.
19. Kayser V, Guilbaud G: Physiological relevance and time-coursc of a tonic endogenous opioid modulation of nociceptive messages, based on the effects of naloxone in a rat model of localized hyperalgesia inflammation, Brain Res 1991:567:197-203.
20. Bcsse D, Lombard MC, Perrot S, Besson JM: Regulation of opioid bindings sites in the superficial dorsal hom of the rat spinal cord following loose ligation of the sciatic nerve: Comparison with sciatic nerve section and lumbar dorsal rhizotomv, Neuroscience 1992:50:921 - 933.
21. Xu XJ, Puke MJC, Verge VMK, Wiesenfeld-Hallin Z, Hughes J, Hokfell T: Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat, Neu-rosciLett 1993:152:129-132.
22. Wiertelak EP, Maier SF, Watkins IR: Cholecystokinin antianalgesia: Safety cues abolish morphine analgesia, Science 1992:256:830- 833.
23. Rowe PM: Excitement overorphanin FQ/noci-ceptin, Lancet 347:606.
24. Ollat H: Traitemenl pharmacologique de la douleur neuropathique, Rev Neurol 1992:148: 521-531.
25. − injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats, Pain 1992;49:279-287.
26. Sindrup SH, Gram LF, Brosen K, et al: The selective serotonin rcuptakc inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms, Pain 1990:42:135- 144.
27. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgenscn T, Gram LF: The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy, Clin Pharmacol Ther 1992;52:547-552.
28. Weihe E, Nohr D, Muller S, Buchler M, Fricss H, Zentel HJ: The tachykinin ncuroimmune connection in inflammatory pain, Ann NY AcadSci 1991:632:283-295.
29. Backonja M, Arendt G, Gombar KA, Check B, Zimmcrmann M: Response of chronic neuropathic pain syndromes to kctamine: A preliminary study, Pain 1994;56:51-57.
30. Kristcnsen JD, Karlsten R, Gordh T, Berge OG: The NMDA antagonist 3-(2-carboxypi-perazinc-4-yl) propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat, Pain 1994;56:59-67.
31. Kayser V, Desmeules JA, Guilbaud G: Effects of noradrenergic agonists on chronic pain models: Arthritic and mononeuropathic rats; in Besson JM, Guilbaud G (eds): Towards the Use of Noradrenergic Agonists for the Treatment of Pain, Amsterdam, Elsevier, 1992. pp 151-167.
32. Sindou M, Mertens P, Keravel Y: Neurochirur-gie de la douleur, Encycl Med Chir Neurologic, Paris, Elsevier, 1996.
33. Jeanmonod D, Magnin M, Morel A: Thalamus and neurogenic pain: Physiological, anatomical and clinical data, Neurorcport 1993:4:475- 478.
34. Katayama Y, Tsubokawa T, Yamamoto T: Chronic motor cortex stimulation for central deaffcrentation pain: Experience with bulbar pain secondary to Wallenberg syndrome, Ste-reotact Funct Neurosurg 1994;62:295-299.
35. Courteix C, Bardin M, Chanteleize C, Lava-renne J, Eschalier A: Study of the sensitivity of the diabetes-induced pain models in rats to a range of analgesics, Pain 1994:57:153-160.
36. Gordh T, Karlsten R, Kristensen J: Intervention with spinal NMDA, adenosine and NO systems for pain modulation, Ann Med 1995: 27:229-234